These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25473896)

  • 21. Histone deacetylase 2 regulates doxorubicin (Dox) sensitivity of colorectal cancer cells by targeting ABCB1 transcription.
    Ye P; Xing H; Lou F; Wang K; Pan Q; Zhou X; Gong L; Li D
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):613-21. PubMed ID: 26846508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
    Ashburner BP; Westerheide SD; Baldwin AS
    Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth.
    Wang Y; Zhang J; Wu L; Liu W; Wei G; Gong X; Liu Y; Ma Z; Ma F; Thiery JP; Chen L
    Breast Cancer Res; 2018 Aug; 20(1):83. PubMed ID: 30071870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of trichostatin A (TSA).
    Agudelo M; Gandhi N; Saiyed Z; Pichili V; Thangavel S; Khatavkar P; Yndart-Arias A; Nair M
    Alcohol Clin Exp Res; 2011 Aug; 35(8):1550-6. PubMed ID: 21447001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects.
    Marshall GM; Gherardi S; Xu N; Neiron Z; Trahair T; Scarlett CJ; Chang DK; Liu PY; Jankowski K; Iraci N; Haber M; Norris MD; Keating J; Sekyere E; Jonquieres G; Stossi F; Katzenellenbogen BS; Biankin AV; Perini G; Liu T
    Oncogene; 2010 Nov; 29(44):5957-68. PubMed ID: 20697349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
    Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
    Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation.
    Borbone E; Berlingieri MT; De Bellis F; Nebbioso A; Chiappetta G; Mai A; Altucci L; Fusco A
    Oncogene; 2010 Jan; 29(1):105-16. PubMed ID: 19802013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
    Koppel I; Timmusk T
    Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2.
    Icardi L; Lievens S; Mori R; Piessevaux J; De Cauwer L; De Bosscher K; Tavernier J
    FASEB J; 2012 Jan; 26(1):240-9. PubMed ID: 21957129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delineating binding potential, stability of Sulforaphane-N-acetyl-cysteine in the active site of histone deacetylase 2 and testing its cytotoxicity against distinct cancer lines through stringent molecular dynamics, DFT and cell-based assays.
    Ganai SA; Srinivasan P; Rajamanikandan S; Shah BA; Mohan S; Gani M; Padder BA; Qadri RA; Bhat MA; Baba ZA; Yatoo MA
    Chem Biol Drug Des; 2021 Sep; 98(3):363-376. PubMed ID: 33966346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of HDAC2 protects the retina from ischemic injury.
    Fan J; Alsarraf O; Dahrouj M; Platt KA; Chou CJ; Rice DS; Crosson CE
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4072-80. PubMed ID: 23696608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
    Buurman R; Sandbothe M; Schlegelberger B; Skawran B
    Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression.
    Morales CR; Li DL; Pedrozo Z; May HI; Jiang N; Kyrychenko V; Cho GW; Kim SY; Wang ZV; Rotter D; Rothermel BA; Schneider JW; Lavandero S; Gillette TG; Hill JA
    Sci Signal; 2016 Apr; 9(422):ra34. PubMed ID: 27048565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
    Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
    Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma.
    Ecker J; Oehme I; Mazitschek R; Korshunov A; Kool M; Hielscher T; Kiss J; Selt F; Konrad C; Lodrini M; Deubzer HE; von Deimling A; Kulozik AE; Pfister SM; Witt O; Milde T
    Acta Neuropathol Commun; 2015 Apr; 3():22. PubMed ID: 25853389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancer.
    Huang R; Langdon SP; Tse M; Mullen P; Um IH; Faratian D; Harrison DJ
    Oncotarget; 2016 Jan; 7(4):4695-711. PubMed ID: 26683361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of histone deacetylase inhibitor on extracellular matrix production in human nasal polyp organ cultures.
    Cho JS; Moon YM; Park IH; Um JY; Kang JH; Kim TH; Lee SH; Kang HJ; Lee HM
    Am J Rhinol Allergy; 2013 Jan; 27(1):18-23. PubMed ID: 23406592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma.
    Wang XF; Qian DZ; Ren M; Kato Y; Wei Y; Zhang L; Fansler Z; Clark D; Nakanishi O; Pili R
    Clin Cancer Res; 2005 May; 11(9):3535-42. PubMed ID: 15867257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trichostatin A, a histone deacetylase inhibitor, reverses epithelial-mesenchymal transition in colorectal cancer SW480 and prostate cancer PC3 cells.
    Wang X; Xu J; Wang H; Wu L; Yuan W; Du J; Cai S
    Biochem Biophys Res Commun; 2015 Jan; 456(1):320-6. PubMed ID: 25434997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.